From February 21, 2024 to March 31, 2024, the company has repurchased 497,440 shares, representing 0.09% for CNY 28.68 million. With this, the company has completed the repurchase of 497,440 shares, representing 0.09% for CNY 28.68 million under the buyback announced on February 21, 2024.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.65 CNY | -0.91% |
|
-1.87% | -19.93% |
07:17am | Autobio Diagnostics Gets Registration Certificates for 14 Devices | MT |
05-21 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.93% | 3.65B | |
-11.88% | 11.36B | |
-15.14% | 7.17B | |
+29.03% | 5.55B | |
+0.86% | 5.33B | |
+7.75% | 2.59B | |
-66.78% | 2.23B | |
-13.76% | 2.2B | |
+25.24% | 2.17B | |
-18.46% | 1.58B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.